Abstract
AbstractA 65‐year‐old Japanese woman with primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma, a rare type with a poor prognosis, is presented. Oral bexarotene and vorinostat were ineffective, and hematopoietic stem cell transplantation was scheduled. We stress that primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma should be treated with bone marrow transplantation when available.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
